| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 113 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 113 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 113 |
| 3 | DOXORUBICIN | 100 |
| 4 | FUROSEMIDE | 86 |
| 5 | BISOPROLOL FUMARATE | 80 |
| 6 | SPIRONOLACTONE | 72 |
| 7 | PACLITAXEL | 70 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 70 |
| 9 | QUETIAPINE | 67 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CENTELLA ASIATICA WHOLE | 1 | 0.1111 |
| 1 | PEMIVIBART | 1 | 0.0233 |
| 2 | MEPIVACAINE HYDROCHLORIDE | 10 | 0.0086 |
| 3 | VERICIGUAT | 6 | 0.0060 |
| 4 | TRANDOLAPRIL TABLETS | 10 | 0.0049 |
| 5 | LOXAPINE | 16 | 0.0040 |
| 6 | TRIHEXYPHENIDYL HYDROCHLORIDE | 4 | 0.0039 |
| 7 | PANTHENOL | 1 | 0.0034 |
| 8 | PSYLLIUM HUSK | 4 | 0.0030 |
| 9 | BEVACIZUMAB-BVZR | 2 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 142 |
| 1 | Atypical Antipsychotic [EPC] | 124 |
| 2 | Alkylating Drug [EPC] | 119 |
| 3 | Loop Diuretic [EPC] | 111 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 5 | Microtubule Inhibitor [EPC] | 105 |
| 6 | Aldosterone Antagonist [EPC] | 101 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 75 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 74 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 17 | 0.0029 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 5 | 0.0024 |
| 3 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 4 | Carnitine Analog [EPC] | 8 | 0.0022 |
| 5 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 3 | 0.0008 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 57 | 0.0008 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 74 | 0.0007 |
| 9 | Aldosterone Antagonist [EPC] | 101 | 0.0006 |